Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration

Stefan Worgall, Gerhard Wolff, Erik Falck-Pedersen, Ronald Crystal

Research output: Contribution to journalArticle

397 Citations (Scopus)

Abstract

To evaluate the contribution of the innate immune component of host defense in clearing the genome of adenovirus (Ad) vectors following in vivo administration, the Ad vectors AdCMV.βgal (expressing β-galactosidase) or AdCMV.Null (expressing no gene) were administered intravenously to immunocompetent or immunodeficient mice, and the amount of vector genome was quantified in the liver. Strikingly, 90% of vector DNA was eliminated within 24 hr. There was no increase in vector DNA in other tissues over this period, suggesting that rapid clearance of vector genome resulted from local degradation. After 24 hr, vector elimination was slow, with only 9% of the initial amount of vector genome cleared over the subsequent 3 weeks. Importantly, early phase (0-24 hr) elimination of vector DNA was independent of the transgene and similar in immunocompetent and nude animals. These observations suggest two phases of Ad vector elimination: a previously recognized late, immune-related elimination, and the early, innate immune elimination described in the present study. The early phase of vector loss is, by far, the dominant mechanism, an observation that has implications in developing strategies to maintain persistent expression of the newly transferred gene following in vivo gene therapy.

Original languageEnglish
Pages (from-to)37-44
Number of pages8
JournalHuman Gene Therapy
Volume8
Issue number1
Publication statusPublished - 1 Jan 1997
Externally publishedYes

Fingerprint

Adenoviridae
Genome
DNA
Galactosidases
Transgenes
Genetic Therapy
Genes
Observation
Liver

ASJC Scopus subject areas

  • Genetics

Cite this

Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. / Worgall, Stefan; Wolff, Gerhard; Falck-Pedersen, Erik; Crystal, Ronald.

In: Human Gene Therapy, Vol. 8, No. 1, 01.01.1997, p. 37-44.

Research output: Contribution to journalArticle

Worgall, Stefan ; Wolff, Gerhard ; Falck-Pedersen, Erik ; Crystal, Ronald. / Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. In: Human Gene Therapy. 1997 ; Vol. 8, No. 1. pp. 37-44.
@article{53646cef492e4bbe845fe58c6d603394,
title = "Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration",
abstract = "To evaluate the contribution of the innate immune component of host defense in clearing the genome of adenovirus (Ad) vectors following in vivo administration, the Ad vectors AdCMV.βgal (expressing β-galactosidase) or AdCMV.Null (expressing no gene) were administered intravenously to immunocompetent or immunodeficient mice, and the amount of vector genome was quantified in the liver. Strikingly, 90{\%} of vector DNA was eliminated within 24 hr. There was no increase in vector DNA in other tissues over this period, suggesting that rapid clearance of vector genome resulted from local degradation. After 24 hr, vector elimination was slow, with only 9{\%} of the initial amount of vector genome cleared over the subsequent 3 weeks. Importantly, early phase (0-24 hr) elimination of vector DNA was independent of the transgene and similar in immunocompetent and nude animals. These observations suggest two phases of Ad vector elimination: a previously recognized late, immune-related elimination, and the early, innate immune elimination described in the present study. The early phase of vector loss is, by far, the dominant mechanism, an observation that has implications in developing strategies to maintain persistent expression of the newly transferred gene following in vivo gene therapy.",
author = "Stefan Worgall and Gerhard Wolff and Erik Falck-Pedersen and Ronald Crystal",
year = "1997",
month = "1",
day = "1",
language = "English",
volume = "8",
pages = "37--44",
journal = "Human Gene Therapy",
issn = "1043-0342",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

TY - JOUR

T1 - Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration

AU - Worgall, Stefan

AU - Wolff, Gerhard

AU - Falck-Pedersen, Erik

AU - Crystal, Ronald

PY - 1997/1/1

Y1 - 1997/1/1

N2 - To evaluate the contribution of the innate immune component of host defense in clearing the genome of adenovirus (Ad) vectors following in vivo administration, the Ad vectors AdCMV.βgal (expressing β-galactosidase) or AdCMV.Null (expressing no gene) were administered intravenously to immunocompetent or immunodeficient mice, and the amount of vector genome was quantified in the liver. Strikingly, 90% of vector DNA was eliminated within 24 hr. There was no increase in vector DNA in other tissues over this period, suggesting that rapid clearance of vector genome resulted from local degradation. After 24 hr, vector elimination was slow, with only 9% of the initial amount of vector genome cleared over the subsequent 3 weeks. Importantly, early phase (0-24 hr) elimination of vector DNA was independent of the transgene and similar in immunocompetent and nude animals. These observations suggest two phases of Ad vector elimination: a previously recognized late, immune-related elimination, and the early, innate immune elimination described in the present study. The early phase of vector loss is, by far, the dominant mechanism, an observation that has implications in developing strategies to maintain persistent expression of the newly transferred gene following in vivo gene therapy.

AB - To evaluate the contribution of the innate immune component of host defense in clearing the genome of adenovirus (Ad) vectors following in vivo administration, the Ad vectors AdCMV.βgal (expressing β-galactosidase) or AdCMV.Null (expressing no gene) were administered intravenously to immunocompetent or immunodeficient mice, and the amount of vector genome was quantified in the liver. Strikingly, 90% of vector DNA was eliminated within 24 hr. There was no increase in vector DNA in other tissues over this period, suggesting that rapid clearance of vector genome resulted from local degradation. After 24 hr, vector elimination was slow, with only 9% of the initial amount of vector genome cleared over the subsequent 3 weeks. Importantly, early phase (0-24 hr) elimination of vector DNA was independent of the transgene and similar in immunocompetent and nude animals. These observations suggest two phases of Ad vector elimination: a previously recognized late, immune-related elimination, and the early, innate immune elimination described in the present study. The early phase of vector loss is, by far, the dominant mechanism, an observation that has implications in developing strategies to maintain persistent expression of the newly transferred gene following in vivo gene therapy.

UR - http://www.scopus.com/inward/record.url?scp=0031034030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031034030&partnerID=8YFLogxK

M3 - Article

C2 - 8989993

AN - SCOPUS:0031034030

VL - 8

SP - 37

EP - 44

JO - Human Gene Therapy

JF - Human Gene Therapy

SN - 1043-0342

IS - 1

ER -